Finance

Beta
Lists
HCAT:NASDAQ
Health Catalyst Inc
$1.74
-9.59%
(-0.18) 1D
$1.74
-0.29% (-0.0050)
Pre-market
Closed: Jun 8, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HCAT...
Open
$1.93
High
$1.98
Low
$1.71
Mkt. cap
128.95M
Avg. vol.
1.62M
Volume
815.00
52-wk high
$4.29
52-wk low
$0.96
EPS
-$3.72
Beta
1.66
Shares outstanding
73.89M
No. of employees
1K
Open
$1.93
High
$1.98
Low
$1.71
Mkt. cap
128.95M
Avg. vol.
1.62M
Volume
815.00
52-wk high
$4.29
52-wk low
$0.96
EPS
-$3.72
Beta
1.66
Shares outstanding
73.89M
No. of employees
1K
Analyst outlook
Analyst Ratings
Based on 9 analysts giving stock ratings to HCAT in the past 3 months
Hold
Buy
2
Hold
7
Sell
0
12 month forecast
Based on 9 Wall Street analysts offering 12 month price targets for HCAT in the last 3 months.
Highest
Current $1.74
$3.00 (+71.92%)
Average
$2.11 (+20.92%)
Lowest
$1.00 (-42.69%)
News stories
From sources across the web
About Health Catalyst Inc
CEODan Burton
Employees1.2K
Founded2008
HeadquartersSouth Jordan, Utah, United States
SectorHealth care
Last report
May 11, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.02 / $0.01
+85.87%beat
Revenue / Est. (USD)
70.76M / 69.19M
+2.26%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
80.72M
76.32M
74.68M
70.76M
Cost of goods sold
42.25M
37.39M
35.29M
34.98M
Cost of revenue
42.25M
37.39M
35.29M
34.98M
Research and development expenses
11.96M
10.91M
9.87M
9.67M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.49M
23.07M
19.85M
20.73M
Operating expense
50.14M
46.59M
42.60M
42.52M
Total operating expenses
92.38M
83.98M
77.88M
77.50M
Operating income
-11.66M
-7.65M
-3.20M
-6.75M
Other non operating income
325.00K
-180.00K
41.00K
-191.00K
EBT including unusual items
-40.90M
-22.19M
-90.65M
-110.61M
EBT excluding unusual items
-15.47M
-12.33M
-7.77M
-10.88M
Income tax expense
81.00K
41.00K
379.00K
414.00K
Effective tax rate
-0.20%
-0.18%
-0.42%
-0.37%
Other operating expenses
-
-
-
-
Net income
-40.98M
-22.23M
-91.02M
-111.03M
Net profit margin
-50.76%
-29.12%
-121.89%
-156.91%
Earnings per share
0.04
0.06
0.08
0.02
Interest and investment income
1.66M
1.14M
909.00K
798.00K
Interest expense
-5.79M
-5.64M
-5.52M
-4.74M
Net interest expenses
-4.13M
-4.50M
-4.61M
-3.94M
Depreciation and amortization charges
12.68M
12.61M
12.88M
12.12M
EBITDA
-1.98M
1.76M
6.28M
1.87M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more